HuagongsheHuagongshe Chemistry Print Report · For research reference only
4-methyl-5-(2-piperazin-1-ylethyl)-2-benzofuran-1(3H)-one hydrochloride → HCID 69087547, compound
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | 4-methyl-5-(2-piperazin-1-ylethyl)-2-benzofuran-1(3H)-one hydrochloride | HCID 67517229 | — |
| Reactant | 3-(1H-tetrazol-1-yl)-6,7-dihydro-5H-cyclopenta[c]pyridine-7-carboxylic acid | HCID 67517230 | — |
| Product | HCID 69087547 | HCID 69087547 | — |
Reaction Steps
4-Methyl-5-[2-(4-{[3-(1H-tetrazol-1-yl)-6,7-dihydro-5H-cyclopenta[c]pyridin-7-yl]carbonyl}piperazin-1-yl)ethyl]-2-benzofuran-1(3H)-one was prepared starting from 3-(1H-tetrazol-1-yl)-6,7-dihydro-5H-cyclopenta[c]pyridine-7-carboxylic acid and 4-methyl-5-(2-piperazin-1-ylethyl)-2-benzofuran-1(3H)-one hydrochloride in an analogous fashion to that described by GENERAL METHOD B. The resulting mixture of two enantiomers was separated by preparative chiral SFC HPLC using a ChiralPak AD-H 250×30 mm I.D. column and eluting with A: SF CO2 and B: ethanol/acetonitrile (2:1) (0.1% DEA) with flow rate of 50 mL/min. The single title isomers were obtained.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US09056859B2 |
| Source dataset | uspto-grants-2015_06 |
| ORD ID | ord-7bc38ffb03b94de381aa49e84515a5a1 |
| Source note | uspto-grants-2015_06 |